Back to Search
Start Over
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): A population-based study
- Source :
- Future Science OA
- Publication Year :
- 2021
-
Abstract
- The Italian municipality of Ariano Irpino (Avellino, Campania, Italy) was locked down by the regional authorities from March until April 2020 after several citizens tested positive for SARS coronavirus 2 (SARS-CoV-2). A serological mass screening campaign targeting the Ariano Irpino population using the Roche Cobas Elecsys anti-SARS-CoV-2 assay was organized by the Zoo-Prophylactic Institute of Southern Italy (Portici, Italy) and conducted in cooperation with the Local Health Unit (Azienda Sanitaria Locale – ASL – Avellino, Avellino, Italy), the Department of Public Health of University Federico II (Naples, Italy) and Department of Health Services of Azienda Ospedaliera dei Colli-Cotugno and Monaldi Hospital (Naples, Italy) in May 2020. A total of 13,218 asymptomatic individuals were reviewed in this analysis. A total of 738 citizens tested positive for anti-SARS-CoV-2 antibodies (398 females, 340 males). The overall prevalence in the sample was 5.6% (95% CI: 5.2–6.0). Among seropositive citizens, 101 cases tested positive on RT-PCR (0.76% of the overall population). Among citizens aged 14–18, 18–65 and >65 years, the seroprevalence was equal to 6.1 (95% CI: 4.1–8.7), 5.6 (95% CI: 5.1–6.1) and 4% (95% CI: 3.3–4.8), respectively. In the pediatric cohort (<br />Lay abstract A mass screening campaign targeting the Ariano Irpino population in Italy, including a total of 13,218 asymptomatic individuals, showed that 5.6% of the tested individuals had antibodies against the virus responsible for COVID-19 in the blood. Among citizens aged 65 years, the proportion of positive individuals was equal to 13, 6.1, 5.6 and 4%, respectively. These asymptomatic individuals, who were identified by a simple blood draw using an inexpensive test (costing only a few euros), could inadvertently spread the infection. A serological-based screening strategy could therefore be a cost-effective public health intervention.
- Subjects :
- 0301 basic medicine
2019-20 coronavirus outbreak
Coronavirus disease 2019 (COVID-19)
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
COVID-19
Virology
Ariano Irpino
Population based study
03 medical and health sciences
Specific antibody
030104 developmental biology
0302 clinical medicine
Geography
Seroprevalence
epidemiology
030212 general & internal medicine
Biotechnology
Research Article
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Future Science OA
- Accession number :
- edsair.doi.dedup.....be7faf7af2b3be939a64abb5705c07df